Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer

ClinicalTrials.gov ID: NCT00042848

Public ClinicalTrials.gov record NCT00042848. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of The Effect Of Modafinil On Fatigue In Cancer Patients Receiving Chemotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Modafinil may be effective in relieving fatigue in patients with cancer who are undergoing chemotherapy. The effectiveness of modafinil in relieving chemotherapy-related fatigue is not yet known. PURPOSE: This randomized phase III trial is studying the effectiveness of modafinil in treating fatigue in patients who are receiving chemotherapy for cancer.

Study identification

NCT ID
NCT00042848
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gary Morrow
Other
Enrollment
837 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2002 (Type not available)
Primary completion
Apr 2007 (Actual)
Completion
Oct 2007 (Actual)
Last update posted
Oct 15, 2015

2002 – 2007

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
31
Facility City State ZIP Site status
MBCCOP - Gulf Coast Mobile Alabama 36606 —
CCOP - Western Regional, Arizona Phoenix Arizona 85006-2726 —
CCOP - Santa Rosa Memorial Hospital Santa Rosa California 95403 —
Medical Center of Aurora - South Campus Aurora Colorado 80012-0000 —
Boulder Community Hospital Boulder Colorado 80301-9019 —
Penrose Cancer Center at Penrose Hospital Colorado Springs Colorado 80933 —
Porter Adventist Hospital Denver Colorado 80210 —
St. Joseph Hospital Denver Colorado 80218-1191 —
Presbyterian - St. Luke's Medical Center Denver Colorado 80218 —
Rocky Mountain Cancer Centers - Denver Rose Denver Colorado 80220 —
CCOP - Colorado Cancer Research Program Denver Colorado 80224 —
Swedish Medical Center Englewood Colorado 80112 —
Sky Ridge Medical Center Lone Tree Colorado 80124 —
Rocky Mountain Cancer Centers - Longmont Longmont Colorado 80501 —
St. Mary-Corwin Regional Medical Center Pueblo Colorado 81004 —
Rocky Mountain Cancer Centers - Thornton Thornton Colorado 80229 —
MBCCOP - Hawaii Honolulu Hawaii 96813 —
MBCCOP - University of Illinois at Chicago Chicago Illinois 60612-7323 —
CCOP - Central Illinois Decatur Illinois 62526 —
CCOP - Evanston Evanston Illinois 60201 —
CCOP - Wichita Wichita Kansas 67214-3882 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
CCOP - Kansas City Kansas City Missouri 64131 —
CCOP - Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
CCOP - Hematology-Oncology Associates of Central New York East Syracuse New York 13057 —
CCOP - North Shore University Hospital Manhasset New York 11030 —
CCOP - Southeast Cancer Control Consortium Goldsboro North Carolina 27534-9479 —
CCOP - Columbus Columbus Ohio 43215 —
CCOP - Dayton Dayton Ohio 45429 —
CCOP - Columbia River Oncology Program Portland Oregon 97225 —
CCOP - Greenville Greenville South Carolina 29615 —
CCOP - Virginia Mason Research Center Seattle Washington 98101 —
CCOP - Northwest Tacoma Washington 98405-0986 —
CCOP - Marshfield Clinic Research Foundation Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00042848, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00042848 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →